Global Venous Access Port Market Size By Type (PICC, Centrally Inserted Catheters (non-tunnelled and tunnelled)), By Application (Hospital, Non-Hospital), By Region, And Segment Forecasts, 2023 to 203...

lobal Venous Access Port Market Report Description

The Global Venous Access Port Market was valued at USD 615.3 million in 2023 and is projected to surpass USD 1,012.7 million by 2031, expanding at a CAGR of 6.5% from 2023 to 2031. The market growth is driven by the increasing incidence of chronic diseases like cancer and renal disorders, which require long-term intravenous therapy. The growing preference for minimally invasive procedures and rising awareness about infection prevention in clinical settings are also fueling the demand for venous access ports globally.

Drivers

Rising Prevalence of Chronic Illnesses

With the growing global burden of chronic diseases such as cancer, end-stage renal disease, and hematologic conditions, there is a surge in demand for long-term vascular access devices. Venous access ports provide a reliable solution for repeated chemotherapy, transfusions, and parenteral nutrition, driving their adoption.

Advancements in Port Design and Materials

Continuous innovations in port materials—such as the development of biocompatible and antimicrobial-coated devices—are improving patient outcomes and reducing infection risks, thereby encouraging wider use.

Increased Surgical and Oncological Procedures

The increasing volume of outpatient and inpatient surgeries, along with advancements in cancer treatments requiring cyclic drug administration, has led to a higher utilization rate of venous access ports in hospitals and oncology centers.

Restraints

High Cost and Limited Accessibility in Low-Income Regions

Venous access ports are associated with high costs, including device procurement, surgical implantation, and maintenance. These costs can be prohibitive in developing countries, restricting market expansion.

Risk of Complications

Although designed for long-term use, venous ports may lead to complications such as thrombosis, infection, or catheter displacement, limiting their usage in certain high-risk patient populations.

Opportunity

Growing Demand in Home Healthcare Settings

The rise of home-based care and remote treatment models presents a major opportunity for market players. Venous ports enable patients to receive complex therapies without prolonged hospital stays, aligning well with current trends in personalized and home care.

Technological Integration and Smart Port Systems

Opportunities exist in the integration of digital monitoring systems and RFID-enabled ports, which allow real-time tracking of port usage and help in better clinical decision-making.

Market by System Type Insights

Based on system type, the single-lumen venous access port segment accounted for the largest market share in 2023. These ports are widely used due to their cost-effectiveness, ease of implantation, and suitability for most oncology and chronic care treatments. However, the multi-lumen segment is expected to grow rapidly as it supports the simultaneous administration of multiple therapies, especially in intensive care and hematology.

Market by End-use Insights

In terms of end use, hospitals dominated the market in 2023 with over 50% revenue share. Hospitals are the primary facilities for port insertion and management, especially for oncology and surgical patients. The home care segment is forecasted to exhibit the highest growth rate during the forecast period, propelled by the shift toward decentralized healthcare models and remote monitoring capabilities.

Market by Regional Insights

North America led the global venous access port market in 2023, driven by advanced healthcare infrastructure, favorable reimbursement policies, and a high incidence of cancer. Asia-Pacific is expected to register the fastest growth rate, supported by rising healthcare expenditures, expanding medical tourism, and increasing awareness of advanced vascular access technologies in countries like China and India.

Competitive Scenario

Key players in the global venous access port market include:

Becton, Dickinson and Company

Teleflex Incorporated

AngioDynamics, Inc.

Smiths Medical

Braun Melsungen AG

Vygon SA

Cook Medical

Medtronic plc

Navilyst Medical

ICU Medical, Inc.

These companies are focusing on product innovation, strategic collaborations, and geographic expansion to strengthen their market presence. For example:

In 2024, BD introduced an advanced antimicrobial-coated port designed to reduce bloodstream infections in long-term cancer care.

Teleflex launched a new titanium-based venous port with improved biocompatibility and ease of use in 2023.

AngioDynamics formed a strategic partnership with a major oncology center to pilot a remote monitoring venous port system.

Scope of Work – Global Venous Access Port Market

Report Metric Details

Market Size (2023) USD 615.3 million

Projected Market Size (2031) USD 1,012.7 million

CAGR (2023–2031) 6.5%

Market Segments By System Type (Single-lumen, Multi-lumen), By End-use (Hospitals, Ambulatory Surgical Centers, Home Care), By Region

Growth Drivers Rise in chronic disease cases, minimally invasive procedures, material innovations

Opportunities Home care integration, digital-enabled port systems

Key Market Developments

March 2024 – BD received FDA clearance for its next-generation venous port with antimicrobial lock technology.

June 2023 – Smiths Medical expanded its distribution network across Asia-Pacific to improve access to advanced vascular access solutions.

September 2022 – Cook Medical launched a patient-centered educational initiative to raise awareness of long-term port usage benefits.

FAQs

What is the current market size of the Global Venous Access Port Market?

The market was valued at USD 615.3 million in 2023.

What is the major growth driver of the Global Venous Access Port Market?

The rising prevalence of chronic diseases and the increasing adoption of